Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Feb;96(2):e5-6; author reply e7-8.
doi: 10.3324/haematol.2010.036061.

Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major

Khaled M Musallam, Ali T Taher
Comment

Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major

Khaled M Musallam et al. Haematologica. 2011 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, et al. Deferasirox, Deferiprone and Desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative Magnetic Resonance Imaging. Haematologica. 2010 doi: 10.3324/haematol.2009.019042. - DOI - PMC - PubMed
    1. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, et al. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood. 2006;107(9):3738–44. - PubMed
    1. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet. 2002;360(9332):516–20. - PubMed
    1. Pennell DJ, Porter JB, Cappellini MD, El-Beshlawy A, Chan LL, Aydinok Y, et al. Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia. Blood. 2010;115(12):2364–71. - PubMed
    1. Wood JC, Kang BP, Thompson A, Giardina P, Harmatz P, Glynos T, et al. The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores. Blood. 2010;116(4):537–43. - PubMed